Cargando…
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
Due to the large number of patients with severe coronavirus disease 2019 (COVID-19), many were treated outside the traditional walls of the intensive care unit (ICU), and in many cases, by personnel who were not trained in critical care. The clinical characteristics and the relative impact of caring...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669808/ https://www.ncbi.nlm.nih.gov/pubmed/35169585 http://dx.doi.org/10.1183/23120541.00552-2021 |
_version_ | 1784614853425496064 |
---|---|
author | Reyes, Luis Felipe Murthy, Srinivas Garcia-Gallo, Esteban Irvine, Mike Merson, Laura Martin-Loeches, Ignacio Rello, Jordi Taccone, Fabio S. Fowler, Robert A. Docherty, Annemarie B. Kartsonaki, Christiana Aragao, Irene Barrett, Peter W. Beane, Abigail Burrell, Aidan Cheng, Matthew Pellan Christian, Michael D. Cidade, Jose Pedro Citarella, Barbara Wanjiru Donnelly, Christl A. Fernandes, Susana M. French, Craig Haniffa, Rashan Harrison, Ewen M. Ho, Antonia Ying Wai Joseph, Mark Khan, Irfan Kho, Michelle E. Kildal, Anders Benjamin Kutsogiannis, Demetrios Lamontagne, François Lee, Todd C. Bassi, Gianluigi Li Lopez Revilla, Jose Wagner Marquis, Catherine Millar, Jonathan Neto, Raul Nichol, Alistair Parke, Rachael Pereira, Rui Poli, Sergio Povoa, Pedro Ramanathan, Kollengode Rewa, Oleksa Riera, Jordi Shrapnel, Sally Silva, Maria Joao Udy, Andrew Uyeki, Timothy Webb, Steve A. Wils, Evert-Jan Rojek, Amanda Olliaro, Piero L. |
author_facet | Reyes, Luis Felipe Murthy, Srinivas Garcia-Gallo, Esteban Irvine, Mike Merson, Laura Martin-Loeches, Ignacio Rello, Jordi Taccone, Fabio S. Fowler, Robert A. Docherty, Annemarie B. Kartsonaki, Christiana Aragao, Irene Barrett, Peter W. Beane, Abigail Burrell, Aidan Cheng, Matthew Pellan Christian, Michael D. Cidade, Jose Pedro Citarella, Barbara Wanjiru Donnelly, Christl A. Fernandes, Susana M. French, Craig Haniffa, Rashan Harrison, Ewen M. Ho, Antonia Ying Wai Joseph, Mark Khan, Irfan Kho, Michelle E. Kildal, Anders Benjamin Kutsogiannis, Demetrios Lamontagne, François Lee, Todd C. Bassi, Gianluigi Li Lopez Revilla, Jose Wagner Marquis, Catherine Millar, Jonathan Neto, Raul Nichol, Alistair Parke, Rachael Pereira, Rui Poli, Sergio Povoa, Pedro Ramanathan, Kollengode Rewa, Oleksa Riera, Jordi Shrapnel, Sally Silva, Maria Joao Udy, Andrew Uyeki, Timothy Webb, Steve A. Wils, Evert-Jan Rojek, Amanda Olliaro, Piero L. |
author_sort | Reyes, Luis Felipe |
collection | PubMed |
description | Due to the large number of patients with severe coronavirus disease 2019 (COVID-19), many were treated outside the traditional walls of the intensive care unit (ICU), and in many cases, by personnel who were not trained in critical care. The clinical characteristics and the relative impact of caring for severe COVID-19 patients outside the ICU is unknown. This was a multinational, multicentre, prospective cohort study embedded in the International Severe Acute Respiratory and Emerging Infection Consortium World Health Organization COVID-19 platform. Severe COVID-19 patients were identified as those admitted to an ICU and/or those treated with one of the following treatments: invasive or noninvasive mechanical ventilation, high-flow nasal cannula, inotropes or vasopressors. A logistic generalised additive model was used to compare clinical outcomes among patients admitted or not to the ICU. A total of 40 440 patients from 43 countries and six continents were included in this analysis. Severe COVID-19 patients were frequently male (62.9%), older adults (median (interquartile range (IQR), 67 (55–78) years), and with at least one comorbidity (63.2%). The overall median (IQR) length of hospital stay was 10 (5–19) days and was longer in patients admitted to an ICU than in those who were cared for outside the ICU (12 (6–23) days versus 8 (4–15) days, p<0.0001). The 28-day fatality ratio was lower in ICU-admitted patients (30.7% (5797 out of 18 831) versus 39.0% (7532 out of 19 295), p<0.0001). Patients admitted to an ICU had a significantly lower probability of death than those who were not (adjusted OR 0.70, 95% CI 0.65–0.75; p<0.0001). Patients with severe COVID-19 admitted to an ICU had significantly lower 28-day fatality ratio than those cared for outside an ICU. |
format | Online Article Text |
id | pubmed-8669808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-86698082021-12-15 Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study Reyes, Luis Felipe Murthy, Srinivas Garcia-Gallo, Esteban Irvine, Mike Merson, Laura Martin-Loeches, Ignacio Rello, Jordi Taccone, Fabio S. Fowler, Robert A. Docherty, Annemarie B. Kartsonaki, Christiana Aragao, Irene Barrett, Peter W. Beane, Abigail Burrell, Aidan Cheng, Matthew Pellan Christian, Michael D. Cidade, Jose Pedro Citarella, Barbara Wanjiru Donnelly, Christl A. Fernandes, Susana M. French, Craig Haniffa, Rashan Harrison, Ewen M. Ho, Antonia Ying Wai Joseph, Mark Khan, Irfan Kho, Michelle E. Kildal, Anders Benjamin Kutsogiannis, Demetrios Lamontagne, François Lee, Todd C. Bassi, Gianluigi Li Lopez Revilla, Jose Wagner Marquis, Catherine Millar, Jonathan Neto, Raul Nichol, Alistair Parke, Rachael Pereira, Rui Poli, Sergio Povoa, Pedro Ramanathan, Kollengode Rewa, Oleksa Riera, Jordi Shrapnel, Sally Silva, Maria Joao Udy, Andrew Uyeki, Timothy Webb, Steve A. Wils, Evert-Jan Rojek, Amanda Olliaro, Piero L. ERJ Open Res Original Research Articles Due to the large number of patients with severe coronavirus disease 2019 (COVID-19), many were treated outside the traditional walls of the intensive care unit (ICU), and in many cases, by personnel who were not trained in critical care. The clinical characteristics and the relative impact of caring for severe COVID-19 patients outside the ICU is unknown. This was a multinational, multicentre, prospective cohort study embedded in the International Severe Acute Respiratory and Emerging Infection Consortium World Health Organization COVID-19 platform. Severe COVID-19 patients were identified as those admitted to an ICU and/or those treated with one of the following treatments: invasive or noninvasive mechanical ventilation, high-flow nasal cannula, inotropes or vasopressors. A logistic generalised additive model was used to compare clinical outcomes among patients admitted or not to the ICU. A total of 40 440 patients from 43 countries and six continents were included in this analysis. Severe COVID-19 patients were frequently male (62.9%), older adults (median (interquartile range (IQR), 67 (55–78) years), and with at least one comorbidity (63.2%). The overall median (IQR) length of hospital stay was 10 (5–19) days and was longer in patients admitted to an ICU than in those who were cared for outside the ICU (12 (6–23) days versus 8 (4–15) days, p<0.0001). The 28-day fatality ratio was lower in ICU-admitted patients (30.7% (5797 out of 18 831) versus 39.0% (7532 out of 19 295), p<0.0001). Patients admitted to an ICU had a significantly lower probability of death than those who were not (adjusted OR 0.70, 95% CI 0.65–0.75; p<0.0001). Patients with severe COVID-19 admitted to an ICU had significantly lower 28-day fatality ratio than those cared for outside an ICU. European Respiratory Society 2022-02-14 /pmc/articles/PMC8669808/ /pubmed/35169585 http://dx.doi.org/10.1183/23120541.00552-2021 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Original Research Articles Reyes, Luis Felipe Murthy, Srinivas Garcia-Gallo, Esteban Irvine, Mike Merson, Laura Martin-Loeches, Ignacio Rello, Jordi Taccone, Fabio S. Fowler, Robert A. Docherty, Annemarie B. Kartsonaki, Christiana Aragao, Irene Barrett, Peter W. Beane, Abigail Burrell, Aidan Cheng, Matthew Pellan Christian, Michael D. Cidade, Jose Pedro Citarella, Barbara Wanjiru Donnelly, Christl A. Fernandes, Susana M. French, Craig Haniffa, Rashan Harrison, Ewen M. Ho, Antonia Ying Wai Joseph, Mark Khan, Irfan Kho, Michelle E. Kildal, Anders Benjamin Kutsogiannis, Demetrios Lamontagne, François Lee, Todd C. Bassi, Gianluigi Li Lopez Revilla, Jose Wagner Marquis, Catherine Millar, Jonathan Neto, Raul Nichol, Alistair Parke, Rachael Pereira, Rui Poli, Sergio Povoa, Pedro Ramanathan, Kollengode Rewa, Oleksa Riera, Jordi Shrapnel, Sally Silva, Maria Joao Udy, Andrew Uyeki, Timothy Webb, Steve A. Wils, Evert-Jan Rojek, Amanda Olliaro, Piero L. Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study |
title | Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study |
title_full | Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study |
title_fullStr | Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study |
title_full_unstemmed | Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study |
title_short | Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study |
title_sort | clinical characteristics, risk factors and outcomes in patients with severe covid-19 registered in the international severe acute respiratory and emerging infection consortium who clinical characterisation protocol: a prospective, multinational, multicentre, observational study |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669808/ https://www.ncbi.nlm.nih.gov/pubmed/35169585 http://dx.doi.org/10.1183/23120541.00552-2021 |
work_keys_str_mv | AT reyesluisfelipe clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT murthysrinivas clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT garciagalloesteban clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT irvinemike clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT mersonlaura clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT martinloechesignacio clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT rellojordi clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT tacconefabios clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT fowlerroberta clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT dochertyannemarieb clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT kartsonakichristiana clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT aragaoirene clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT barrettpeterw clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT beaneabigail clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT burrellaidan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT chengmatthewpellan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT christianmichaeld clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT cidadejosepedro clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT citarellabarbarawanjiru clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT donnellychristla clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT fernandessusanam clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT frenchcraig clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT haniffarashan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT harrisonewenm clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT hoantoniayingwai clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT josephmark clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT khanirfan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT khomichellee clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT kildalandersbenjamin clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT kutsogiannisdemetrios clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT lamontagnefrancois clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT leetoddc clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT bassigianluigili clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT lopezrevillajosewagner clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT marquiscatherine clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT millarjonathan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT netoraul clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT nicholalistair clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT parkerachael clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT pereirarui clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT polisergio clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT povoapedro clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT ramanathankollengode clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT rewaoleksa clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT rierajordi clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT shrapnelsally clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT silvamariajoao clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT udyandrew clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT uyekitimothy clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT webbstevea clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT wilsevertjan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT rojekamanda clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT olliaropierol clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy AT clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy |